How patients in Denmark acquire their medicines: overview, data sources and implications for pharmacoepidemiology
Research output: Contribution to journal › Review › Research › peer-review
Standard
How patients in Denmark acquire their medicines : overview, data sources and implications for pharmacoepidemiology. / Jensen, Thomas B.; Andersen, Jon T.; Jimenez-Solem, Espen; Lund, Marie.
In: Basic and Clinical Pharmacology and Toxicology, Vol. 128, No. 1, 2021, p. 46-51.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - How patients in Denmark acquire their medicines
T2 - overview, data sources and implications for pharmacoepidemiology
AU - Jensen, Thomas B.
AU - Andersen, Jon T.
AU - Jimenez-Solem, Espen
AU - Lund, Marie
N1 - Funding Information: Thomas Bo Jensen was supported by an unrestricted research grant from Helsefonden (grant number: 18‐B‐0205). Publisher Copyright: © 2020 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society)
PY - 2021
Y1 - 2021
N2 - The means by which patients acquire their medications differ between countries, and a knowledge of this is essential when conducting and interpreting pharmacoepidemiological studies. The aim of this paper is to provide an overview of how patients obtain medicines in Denmark, to relate these to nationwide registries available for research and to discuss the implications for research. Health services are predominantly tax-funded in Denmark, with dentistry and some medicine bought at community pharmacies being exceptions, involving partial reimbursement of charges. The paper gives an overview of prescription medicines acquired from community pharmacies (including magistral preparations), over-the-counter medicines, vaccinations and in-hospital medicine including so-called “free medicine” (in Danish: “vederlagsfri medicin”). “Free medicine” is medicines for a defined list of diseases and indications that is provided free of charge to patients in outpatient clinics. The paper also describes the content of the various Danish data sources about medicine use, summarizes their strengths and limitations, and exemplifies the ways of evaluating their completeness. An example is provided of the regional variation in the means by which medicines are acquired.
AB - The means by which patients acquire their medications differ between countries, and a knowledge of this is essential when conducting and interpreting pharmacoepidemiological studies. The aim of this paper is to provide an overview of how patients obtain medicines in Denmark, to relate these to nationwide registries available for research and to discuss the implications for research. Health services are predominantly tax-funded in Denmark, with dentistry and some medicine bought at community pharmacies being exceptions, involving partial reimbursement of charges. The paper gives an overview of prescription medicines acquired from community pharmacies (including magistral preparations), over-the-counter medicines, vaccinations and in-hospital medicine including so-called “free medicine” (in Danish: “vederlagsfri medicin”). “Free medicine” is medicines for a defined list of diseases and indications that is provided free of charge to patients in outpatient clinics. The paper also describes the content of the various Danish data sources about medicine use, summarizes their strengths and limitations, and exemplifies the ways of evaluating their completeness. An example is provided of the regional variation in the means by which medicines are acquired.
KW - drug prescriptions (MeSH)
KW - electronic health records (MeSH)
KW - in-hospital drug use
KW - non-prescription drugs (MeSH)
KW - pharmacoepidemiology (MeSH)
U2 - 10.1111/bcpt.13472
DO - 10.1111/bcpt.13472
M3 - Review
C2 - 32657031
AN - SCOPUS:85088557363
VL - 128
SP - 46
EP - 51
JO - Basic and Clinical Pharmacology and Toxicology
JF - Basic and Clinical Pharmacology and Toxicology
SN - 1742-7835
IS - 1
ER -
ID: 280238666